Gambian children successfully treated with chloroquine can harbor and transmit Plasmodium falciparum gametocytes carrying resistance genes

American Journal of Tropical Medicine and Hygiene

Volumn 67, Issue 6, 2002, Pages 578-585

  Sutherland, Colin J ^a,b,c   Alloueche, Ali ^a,b,c   Curtis, Jill ^a,b,c   Drakeley, Chris J ^a,b,c   Ord, Rosalynn ^a,b,c   Duraisingh, Manoj ^a,b,c   Greenwood, Brian M ^a,b,c   Pinder, Margaret ^b,c,d   Warhurst, David ^a,b,c   Targett, Geoffrey A T ^a,b,c  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b Joint Malaria Program   (Tanzania)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; CHLOROQUINE; FANSIDAR; THREONINE;

ALLELE; ANOPHELES; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GAMBIA; GAMETOCYTE; GENE AMPLIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC RESISTANCE; GENOTYPE; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MULTIDRUG RESISTANCE; PARASITE TRANSMISSION; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE; TROPHOZOITE;

ANOPHELES MOSQUITO; ARTESUNATE; PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0036912984     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2002.67.578     Document Type: Article

References (37)

1. Menon A, Otoo LN, Herbage EA, Greenwood BM, 1990. A national survey of the prevalence of chloroquine resistant Plasmodium falciparum malaria in The Gambia. Trans R Soc Trop Med Hyg 84: 638-640.
2. Muller O. Boele van Hensbroek M, Jaffar S, Drakeley C, Okorie C, Joof D, Pinder M, Greenwood B, 1996. A randomised trial of chloroquine, amodiaquine and pyrimethamine-sulphadoxine in Gambian children with uncomplicated malaria. Trop Med Int Health 1: 124-132.
3. von Seidlein L, Duraisingh MT, Drakeley CJ, Bailey R, Greenwood BM, Pinder M, 1997. Polymorphism of the Pfmdr1 gene and chloroquine resistance in Plasmodium falciparum in The Gambia. Trans R Soc Trop Med Hyg 91: 450-453.
4. Trape JF, Pison G, Preziosi MP, Enel C, Desgrees du Lou A, Delaunay V, Samb B, Lagarde E, Molez JF, Simondon F, 1998. Impact of chloroquine resistance on malaria mortality. C R Acad SciIII 321: 689-697.
5. Warhurst DC, 2001. A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med 344: 299-302.
6. Duraisingh MT, Drakeley CJ, Muller O, Bailey R, Snounou G, Targett GAT, Greenwood BM, Warhurst DC, 1997. Evidence for selection for the tyrosine-86 allele of the pfmdr 1 gene of Plasmodium falciparum by chloroquine and amodiaquine Parasitology 114: 205-211.
7. Duraisingh MT, von Seidlein L, Jepson A, Jones P, Sambou I, Pinder M, Warhurst DC, 2000. Linkage disequilibrium between two chromosomally distinct loci associated with increased resistance to chloroquine in Plasmodium falciparum. Parasitology 121: 1-8.
8. Adagu IS, Warhurst DC, 2001. Plasmodium falciparum: Linkage disequilibrium between loci in chromosomes 7 and 5 and chloroquine selective pressure in northern Nigeria. Parasitology 123: 219-224.
9. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LMB, Sidhu AB, Naude B, Deitsch KW, Su X-Z, Wootton JC, Roepe PD, Wellems TE, 2000. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell 6: 861-871.
10. Djimde A, Duombo OK, Cortese JF, Kayentao K, Duombo S, Diourte Y, Dicko A, Su X-Z, Nomura T, Fidock D, Wellems TE, Plowe CV, 2001. A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med 344: 257-301.
11. Pillai DR, Labbe AC, Vanisaveth V, Hongvangthong B, Pomphida S, Inkathone S, Zhong K, Kain KC, 2001. Plasmodium falciparum malaria in Laos: Chloroquine treatment outcome and predictive value of molecular markers. J Infect Dis 183: 789-795.
12. Durand R, Jafari S, Vauzelle J, Delabre JF, Jesic Z, Le Bras J, 2001. Analysis of pfcrt point mutations and chloroquine susceptibility in isolates of Plasmodium falciparum. Mol Biochem Parasitol 114: 95-102.
13. Flueck TPF, Jelinek T, Kilian AHD, Adagu IS, Kabagambe G, von Sonnenburg F, Warhurst DC, 2000. Correlation of in vivo resistance to chloroquine and allelic polymorphisms in Plasmodium falciparum isolates from Uganda. Trop Med Int Health 5: 174-178.
14. Tyr polymorphisms, thought to be associated with chloroquine resistance, are present in chloroquine-resistant and -sensitive Brazilian field isolates of Plasmodium falciparum. Exp Parasitol 88: 64-68.
15. Price RN, Cassar C, Brockman A, Duraisingh M, van Vugt M, White NJ, Nosten F, Krishna S, 1999. The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Antimicrob Agents Chemother 43: 2943-2949.
16. Basco LK, Ringwald P, 2001. Analysis of the key pfcrt point mutation and in vitro and in vivo response to chloroquine in Yaounde. Cameroon J Infect Dis. 183: 1828-1831.
17. Targett G, Drakeley C, Jawara M, von Seidlein L, Coleman R, Deen J, Pinder M, Doherty T, Sutherland C, Walraven G, Milligan P, 2001. Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae J Infect Dis 183: 1254-1259.
18. von Seidlein L, Jawara M, Coleman R, Doherty T, Walraven G, Targett G, 2001. Parasitaemia and gametocytaemia after treatment with chloroquine, pyrimethamine/sulfadoxine, and pyrimethamine/sulfadoxine combined with artesunate in young Gambians with uncomplicated malaria. Trop Med Int Health 6: 92-98.
19. WHO Regional Office for Africa, 1999. A Practical Handbook for Antimalarial Drug Therapeutic Efficacy Testing for the District Health Worker. Geneva: World Health Organization.
20. Alloueche A, Silveira H, Conway DJ, Bojang K, Doherty T, Cohen J, Pinder M, Greenwood B, 2000. High-throughput sequence typing of T-cell epitope polymorphisms in Plasmodium falciparum circumsporozoite protein. Mol Biochem Parasitol 106:273-282.
21. Conway DJ, Roper C, Oduola AMJ, Arnot DE, Kremsner PG, Grobusch MP, Curtis CF, Greenwood BM, 1999. High recombination rate in natural populations of Plasmodium falciparum. Proc Natl Acad Sci USA 96: 4506-4511.
22. Sutherland CJ, Alloueche A, McRobert A, Ord A, Leggat J, Snounou G, Pinder M, Targett GAT, 2002. Genetic complexity of Plasmodium falciparum gametocytes isolated from the peripheral blood of treated Gambian children. Am J Trop Med Hyg 66: 700-705.
23. Warhurst DC, 2001. New developments: Chloroquine-resistance in Plasmodium falciparum. Drug Resistance Update 4:141-144.
24. Babiker HA, Pringle SJ, Abdel-Muhsin A, Mackinnon M, Hunt P, Walliker D, 2001. High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance gene pfmdr1. J Infect Dis 183: 1535-1538.
25. Mehlotra RK, Fujioka H, Roepe PD, Janneh O, Ursos LM, Jacobs-Lorena V, McNamara DT, Bockarie MJ, Kazura JW, Kyle DE, Fidock DA, Zimmerman PA, 2001. Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America. Proc Natl Acad Sci U S A 98: 12689-12694.
26. Snounou G, Beck H.-P, 1998. The use of PCR genotyping in the assessment of recrudescence or reinfection after antimalarial drug treatment. Parasitol Today 14: 462-467.
27. Hay SI, Rogers DJ, Toomer JF, Snow RW, 2000. Annual Plasmodium falciparum entomological inoculation rates (EIR) across Africa: Literature survey, Internet access and review. Trans R Soc Trop Med Hyg 94: 113-127.
28. Dollery C, ed, 1999. Therapeutic Drugs. Second edition. London: Churchill Livingstone.
29. Bruce-Chwatt LJ, ed, 1986. Chemotherapy of Malaria. Second Edition. Geneva: World Health Organization. Monograph, no. 27.
30. Babiker HA, Ranford-Cartwright LC, Sultan A, Satti G, Walliker D, 1994. Genetic evidence that RI chloroquine resistance of Plasmodium falciparum is caused by recrudescence of resistant parasites. Trans R Soc Trop Med Hyg 88: 328-331.
31. Basco LK, Ringwald P, 2000. Molecular epidemiology of malaria in Yaounde, Cameroon. VII. Analysis of recrudescence and reinfection in patients with uncomplicated falciparum malaria Am J Trop Med Hyg 63: 215-221.
32. Ranford-Cartwright LC, Taylor J, Umasunthar T, Taylor LH, Babiker HA, Lell B, Schmidt-Ott JR, Lehmann LG, Walliker D, Kremsner PG, 1997. Molecular analysis of recrudescent parasites in a Plasmodium falciparum drug efficacy trial in Gabon. Trans R Soc Trop Med Hyg 91: 710-724.
33. Brockman A, Paul REL, Anderson TJC, Hackford I, Phaiphun L, Looareesuwan S, Nosten F, Day KP, 1999. Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand. Am J Trop Med Hyg 60:14-21.
34. Djimde A, Doumbo OK, Steketee RW, Plowe CV, 2001. Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria. Lancet 358: 890-891.
35. White NJ, Nosten F, Looareesuwan S, Watkins WM, Marsh K, Snow RW, Kokwaro G, Ouma J, Hien TT, Molyneux ME, Taylor TE, Newbold CI, Ruebush TK II, Danis M, Greenwood BM, Anderson RM, Olliaro P, 1999. Averting a malaria disaster. Lancet 333: 1965-1967.
36. von Seidlein L, Milligan P, Pinder M, Bojang K, Anyalebechi C, Gosling R, Coleman R, Ude JI, Sadiq A, Duraisingh M, Warhurst D, Alloueche A, Targett G, McAdam K, Greenwood B, Walraven G, Olliaro P, Doherty T, 2000. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: A double-blind, randomised, controlled trial. Lancet 355: 352-357.
37. Price R, Nosten F, Luxemburger C, Kuile FOT, Paiphun L, Chongsuphajaisiddhi T, White NJ, 1996. Effects of artemisinin derivatives on malaria transmissibility. Lancet 347: 1654-1658.